CAVALIER JASON (Chief Financial Officer) received a stock award from LYRA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/18/2024ACC: 0000950170-24-115594
Officer· Chief Financial Officer
Since Sep 2021
+100K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
—
Trade value
—
% of position
New position
10/16/2024
0.00→100K
Total
Net shares
+100K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/16/2024 | A · Award | +100K | — | — | New position | 0.00 | 100K |
| Total | +100K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported